Press Release

ZELTIQ Aesthetics to Sell to Allergan for $2.5 Billion

February 14, 2017

San Diego ­­– February 14, 2017 – Cooley is advising ZELTIQ Aesthetics (NASDAQ: ZLTQ) on its approximately $2.5 billion all cash sale to Allergan (NYSE: AGN), a leading global biopharmaceutical company. The deal is expected to close in the second half of the year, subject to shareholder and regulatory approval.

ZELTIQ is a medtech company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. The CoolSculpting system is US FDA-approved to freeze fat cells, causing them to self-destruct over several months. According to an article in the WSJ, “The treatment, currently done at dermatologists, plastic surgeons and other doctors’ offices, is approved to reduce fat at the love handles, abdomen, thighs and below the chin.”

“Allergan's world-class medical aesthetics products, global footprint, history and commitment to developing best-in-class aesthetic treatments makes the company ideally suited to realize the maximum commercial potential of the ZELTIQ controlled-cooling technology platform,” said Mark Foley, CEO of ZELTIQ.

“By adding the best-in-class body contouring CoolSculpting System to our best-in-class facial aesthetics, plastic surgery and regenerative medicine offerings we are creating a world-class aesthetics business,” said Brent Saunders, Allergan CEO in the company press release.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.